Status:
COMPLETED
n-3 Polyunsaturated Fatty Acids in Obesity
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
National Bank of Austria
Conditions:
Adipose Tissue Inflammation
Morbid Obesity
Eligibility:
All Genders
20-65 years
Phase:
PHASE2
Brief Summary
Inflammation in the adipose (fat) tissue is an important condition leading to metabolic derangements and cardiovascular disease in obese patients. n-3 polyunsaturated fatty acids exert anti-inflammato...
Eligibility Criteria
Inclusion
- Non-diabetic morbidly obese patients (BMI \> 40 kg/m2) supposed to undergo bariatric surgery
- Age 20-65 yrs
Exclusion
- Acute illness within the last two week
- Known diabetes mellitus or current anti-diabetic medication
- Acquired immunodeficiency (HIV infection)
- Hepatitis or other significant liver disease
- Severe or untreated cardiovascular, renal, pulmonary disease
- Untreated or inadequately treated clinically significant thyroid disease
- Anemia
- Active malignant disease
- Inborn or acquired bleeding disorder including warfarin treatment
- Pregnancy or breast feeding
- Drug intolerability that prohibits the use of the study drug
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2016
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT00760760
Start Date
September 1 2008
End Date
March 1 2016
Last Update
March 16 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090